Grants per year
Personal profile
Research Interests
Dermatopharmacology
Training Experience
| 1968 | Residency, University of Chicago |
Education/Academic qualification
PhD, Pacific Western University
… → 1993
Research interests
- Clinical Pharmacology
- Clinical Trial Methodology
- Dermatology
- Drug Discovery
- Drugs (clinical pharmacology)
- Pharmacology
- Pharmacovigilance
- Quality of Life
Fingerprint Dive into the research topics where Dennis P West is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Drug-Related Side Effects and Adverse Reactions
Medicine & Life Sciences
Skin
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Minoxidil
Medicine & Life Sciences
Psoriasis
Medicine & Life Sciences
United States Food and Drug Administration
Medicine & Life Sciences
Skin Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2001 2022
Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure
Miller, S. D., West, D. P. & Lu, K.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/1/18 → 7/31/22
Project: Research project
Drug Repositioning
Mustard Plant
Skin
Spironolactone
Diphosphonates
EHR Anticoagulants Pharmacovigilance
University of Massachusetts Lowell, National Heart, Lung, and Blood Institute
1/22/18 → 11/30/19
Project: Research project
Data warehouses
Industry
Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure
Case Western Reserve University, National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/4/17 → 7/31/18
Project: Research project
Drug Repositioning
Mustard Plant
Animal Models
Pharmaceutical Preparations
Allergy and Immunology
Domain-Specific Language Design for Patient-Oriented Prescriptions
Belknap, S. M., West, D. P. & West, D. P.
9/1/15 → 8/31/18
Project: Research project
Computer science
Computer programming languages
Software design
DSL
Software reliability
Research Output 1977 2019
Current Advances in the Prevention, Risk, and Management of Infection in Patients Receiving Biologic Therapy for Dermatologic Disorders
Kosche, C. A., Ali, Y., Figueiredo, A. C., West, D. P. & Nardone, B., Sep 15 2019, In : Current Dermatology Reports. 8, 3, p. 141-148 8 p.Research output: Contribution to journal › Review article
Biological Therapy
Risk Management
Infection
Biological Factors
LY2439821
Effect of postinjection facial exercise on time of onset of botulinum toxin for glabella and forehead wrinkles: A randomized, controlled, crossover clinical trial
Alam, M., Geisler, A., Warycha, M., Paghdal, K., Roongpisuthipong, W., Schlessinger, D. I., Chen, B. R., Reynolds, K. A., West, D. P. & Samuelson, E. P., Apr 1 2019, In : Journal of the American Academy of Dermatology. 80, 4, p. 1144-1147 4 p.Research output: Contribution to journal › Article
Forehead
Botulinum Toxins
Cross-Over Studies
Randomized Controlled Trials
Frequency of acne in lactose-intolerant adults: a retrospective cross-sectional analysis within a large Midwestern US patient population
Orrell, K. A., Kelm, R. C., Murphrey, M., Nagiredla, S., Wu, B., Abu-Zayed, H., Schlosser, B. J., West, D. P. & Nardone, B., May 1 2019, In : Journal of the European Academy of Dermatology and Venereology. 33, 5, p. e190-e191Research output: Contribution to journal › Letter
Acne Vulgaris
Lactose
Cross-Sectional Studies
Population
Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program
Thiede, R. M., Rastogi, S., Nardone, B., Sadowsky, L. M., Rangel, S. M., West, D. P. & Schlosser, B. J., Jul 1 2019, In : International Journal of Women's Dermatology. 5, 3, p. 155-157 3 p.Research output: Contribution to journal › Article
Open Access
Spironolactone
Hyperkalemia
Acne Vulgaris
Drug-Related Side Effects and Adverse Reactions
Retrospective Studies
Incidence of cutaneous adverse events after exposure to tenofovir–emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program
Kosche, C., Para, A., Brieva, J. C., West, D. P., Palella, F. J. & Nardone, B., Jan 1 2019, In : Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Letter
Tenofovir
Pharmacovigilance
Drug-Related Side Effects and Adverse Reactions
HIV
Skin